OtherPerspective

Early detection of gastric cancer in China: progress and opportunities

Hengmin Xu and Wenqing Li
Cancer Biology & Medicine December 2022, 19 (12) 1622-1628; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0655

References

  1. 1.↵
    2. Wei WQ,
    3. Zeng HM,
    4. Zheng RS,
    5. Zhang SW,
    6. An L,
    7. Chen R, et al.
    Cancer registration in China and its role in cancer prevention and control. Lancet Oncol. 2020; 21: e342–9.
    OpenUrlPubMed
  2. 2.↵
    2. Li WQ,
    3. Qin XX,
    4. Li ZX,
    5. Wang LH,
    6. Liu ZC,
    7. Fan XH, et al.
    Beneficial effects of endoscopic screening on gastric cancer and optimal screening interval: a population-based study. Endoscopy. 2022; 54: 848–58.
    OpenUrl
  3. 3.↵
    2. Sung H,
    3. Ferlay J,
    4. Siegel RL,
    5. Laversanne M,
    6. Soerjomataram I,
    7. Jemal A, et al.
    Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021; 71: 209–49.
    OpenUrl
  4. 4.
    2. Zheng RS,
    3. Zhang SW,
    4. Zeng HM,
    5. Wang SM,
    6. Sun KX,
    7. Chen R, et al.
    Cancer incidence and mortality in China, 2016. J Natl Cancer Center. 2022; 2: 1–9.
    OpenUrl
  5. 5.↵
    2. Cao MM,
    3. Li H,
    4. Sun DQ,
    5. He SY,
    6. Yan XX,
    7. Yang F, et al.
    Current cancer burden in China: epidemiology, etiology, and prevention. Cancer Biol Med. 2022; 19: 1121–38.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    2. You WC,
    3. Li JY,
    4. Blot WJ,
    5. Chang YS,
    6. Jin ML,
    7. Gail MH, et al.
    Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer. 1999; 83: 615–9.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    2. Fan XH,
    3. Qin XX,
    4. Zhang Y,
    5. Li ZX,
    6. Zhou T,
    7. Zhang JY, et al.
    Screening for gastric cancer in China: advances, challenges and visions. Chin J Cancer Res. 2021; 33: 168–80.
    OpenUrlPubMed
  8. 8.↵
    2. Chen R,
    3. Liu Y,
    4. Song GH,
    5. Li BY,
    6. Zhao DL,
    7. Hua ZL, et al.
    Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study. Gut. 2021; 70: 251.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    2. Fitzgerald RC,
    3. Antoniou AC,
    4. Fruk L,
    5. Rosenfeld N.
    The future of early cancer detection. Nat Med. 2022; 28: 666–77.
    OpenUrlPubMed
  10. 10.↵
    2. You WC,
    3. Blot WJ,
    4. Li JY,
    5. Chang YS,
    6. Jin ML,
    7. Kneller R, et al.
    Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res. 1993; 53: 1317–21.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    2. You WC,
    3. Zhang L,
    4. Gail MH,
    5. Li JY,
    6. Chang YS,
    7. Blot WJ, et al.
    Precancerous lesions in two counties of China with contrasting gastric cancer risk. Int J Epidemiol. 1998; 27: 945–8.
    OpenUrlCrossRefPubMed
  12. 12.↵
    2. You WC,
    3. Zhao L,
    4. Chang YS,
    5. Blot WJ,
    6. Fraumeni JF, Jr..
    Progression of precancerous gastric lesions. Lancet. 1995; 345: 866–7.
    OpenUrlPubMedWeb of Science
  13. 13.↵
    2. You WC.
    Progress in early detection and treatment for gastric cancer. China Cancer. 2009; 18: 695–9.
    OpenUrl
  14. 14.↵
    2. Yuan Y,
    3. Zhang YC.
    A report of prevention and control scene for gastric cancer in Zhuanghe region, Liaoning Province. China Cancer. 2009; 18: 14–7.
    OpenUrl
  15. 15.↵
    China’s National Bureau for Disease Control and Prevention CFoC, Expert Committee of Cancer Early diagnosis and Treatment Program in rural areas. Work report on the early diagnosis and early treatment for cancers in rural areas (2021). 2021.
  16. 16.↵
    2. Chen WQ.
    Progress of Cancer Screening Program in Urban China. China Cancer. 2019; 28: 23–5.
    OpenUrl
  17. 17.↵
    2. Xia RY,
    3. Zeng HM,
    4. Liu WJ,
    5. Xie L,
    6. Shen MW,
    7. Li P, et al.
    Estimated cost-effectiveness of endoscopic screening for upper gastrointestinal tract cancer in high-risk areas in China. JAMA Netw Open. 2021; 4: e2121403.
  18. 18.↵
    2. Wang ZX,
    3. Han W,
    4. Xue F,
    5. Zhao YJ,
    6. Wu P,
    7. Chen YL, et al.
    Nationwide gastric cancer prevention in China, 2021–2035: a decision analysis on effect, affordability and cost-effectiveness optimisation. Gut. 2022; 71: 2391–400 .
    OpenUrlAbstract/FREE Full Text
  19. 19.
    2. Miki K.
    Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels—“ABC method”. Proc Jpn Acad Ser B Phys Biol Sci. 2011; 87: 405–14.
    OpenUrlCrossRefPubMed
  20. 20.
    2. Tu HK,
    3. Sun LP,
    4. Dong X,
    5. Gong YH,
    6. Xu Q,
    7. Jing JJ, et al.
    A serological biopsy using five stomach-specific circulating biomarkers for gastric cancer risk assessment: a multi-phase study. Am J Gastroenterol. 2017; 122: 704–15.
    OpenUrl
  21. 21.
    2. Cai QC,
    3. Zhu CP,
    4. Yuan Y,
    5. Feng Q,
    6. Feng YC,
    7. Hao YX, et al.
    Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019; 68: 1576–87.
    OpenUrlAbstract/FREE Full Text
  22. 22.
    2. Shida A,
    3. Fukuyama T,
    4. Futawatari N,
    5. Ohmiya H,
    6. Ichiki Y,
    7. Yamashita T, et al.
    Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers. World J Gastroenterol. 2020; 26: 424–32.
    OpenUrl
  23. 23.
    2. Zeng WW,
    3. Zhang SX,
    4. Yang L,
    5. Wei WC,
    6. Gao J,
    7. Guo N, et al.
    Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer. BMC Med Genet. 2020; 21: 1–7.
    OpenUrlCrossRef
  24. 24.↵
    2. Huang XZ,
    3. Gao P,
    4. Sun JX,
    5. Chen XW,
    6. Song YX,
    7. Zhao JH, et al.
    Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer: a meta-analysis. Int J Cancer. 2015; 136: 21–33.
    OpenUrl
  25. 25.↵
    2. Tang LH,
    3. Zhao SS,
    4. Liu W,
    5. Parchim NF,
    6. Huang J,
    7. Tang YH, et al.
    Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis. BMC Cancer. 2013; 13: 1–15.
    OpenUrlCrossRefPubMed
  26. 26.↵
    2. Chen XD,
    3. Gole J,
    4. Gore A,
    5. He QY,
    6. Lu M,
    7. Min J, et al.
    Non-invasive early detection of cancer four years before conventional diagnosis using a blood test. Nat Commun. 2020; 11: 1–10.
    OpenUrlCrossRefPubMed
  27. 27.↵
    2. Jin GF,
    3. Lv J,
    4. Yang M,
    5. Wang MY,
    6. Zhu M,
    7. Wang TP, et al.
    Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol. 2020; 21: 1378–86.
    OpenUrl
  28. 28.↵
    2. Li X,
    3. Zheng NR,
    4. Wang LH,
    5. Li ZW,
    6. Liu ZC,
    7. Fan H, et al.
    Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer. EBioMedicine. 2021; 74: 103714.
  29. 29.↵
    2. Huang S,
    3. Guo Y,
    4. Li ZW,
    5. Shui GH,
    6. Tian H,
    7. Li BW, et al.
    Identification and validation of plasma metabolomic signatures in precancerous gastric lesions that progress to cancer. JAMA Netw Open. 2021; 4: e2114186.
  30. 30.↵
    2. Zhou CB,
    3. Pan SY,
    4. Jin P,
    5. Deng JW,
    6. Xue JH,
    7. Ma XY, et al.
    Fecal signatures of Streptococcus anginosus and Streptococcus constellatus for non-invasive screening and early warning of gastric cancer. Gastroenterology. 2022; 162: 1933–47.
    OpenUrl
  31. 31.↵
    2. Li WQ,
    3. Zhang JY,
    4. Ma JL,
    5. Li ZX,
    6. Zhang L,
    7. Zhang Y, et al.
    Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial. BMJ. 2019; 366: l5016.
  32. 32.
    2. Guo Y,
    3. Li ZX,
    4. Zhang JY,
    5. Ma JL,
    6. Zhang L,
    7. Zhang Y, et al.
    Association between lifestyle factors, vitamin and garlic supplementation, and gastric cancer outcomes: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2020; 3: e206628.
  33. 33.↵
    2. Lee HW,
    3. Huang D,
    4. Shin WK,
    5. de la Torre K,
    6. Song M,
    7. Shin A, et al.
    Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study. Cancer Biol Med. 2022; 19: 1224–34.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    2. Hamashima C.
    Update version of the Japanese Guidelines for Gastric Cancer Screening. Jpn J Clin Oncol. 2018; 48: 673–83.
    OpenUrlPubMed
  35. 35.↵
    Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean practice guideline for gastric cancer 2018: an evidence-based, multi-disciplinary approach. J Gastric Cancer. 2019; 19: 1–48.
    OpenUrl
  36. 36.↵
    2. He J,
    3. Chen WQ,
    4. Li ZS,
    5. Li N,
    6. Ren JS,
    7. Tian JH, et al.
    China guideline for the screening, early detection and early treatment of gastric cancer (2022, Beijing). Zhonghua Zhong Liu Za Zhi [Chinese J Oncol]. 2022; 44: 634–66.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section